Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1508.6000 31.50 (2.13%)
NSE Oct 16, 2026 15:31 PM
Volume: 213.0K
 

logo
Rubicon Research Ltd.
18 Nov 2025
1508.60
2.13%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research has gained 140.15% in the last 1 Year
More from Rubicon Research Ltd.
Recommended
Five Interesting Stocks Today - October 16, 2026
The Baseline | 16 Oct 2026, 05:24PM
Market closes higher, led by gains in IT and metal stocks
Trendlyne Marketwatch | 16 Oct 2026, 04:06PM
'Mehengai' is back in the headlines, with crude at $106 and wholesale inflation at 11.4%
The Baseline | 15 Oct 2026, 12:00PM